Ipilimumab in treatment-naive and previously treated patients with metastatic melanoma: retrospective analysis of efficacy and safety data from a phase II trial.

Thompson, John A; Hamid, Omid; Minor, David; Amin, Asim; Ron, Ilan G; Ridolfi, Ruggero; Assi, Hazem; Berman, David; Siegel, Jonathan; Weber, Jeffrey S

Thompson, John A; Hamid, Omid; Minor, David; Amin, Asim; Ron, Ilan G; Ridolfi, Ruggero; Assi, Hazem; Berman, David; Siegel, Jonathan; Weber, Jeffrey S.

Affiliation

Thompson JA; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA. jat@u.washington.edu

J Immunother ; 35(1): 73-7, 2012 Jan.

Article in En | MEDLINE | ID: mdl-22130164

Subject(s)

Antibodies, Monoclonal/administration & dosage; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; Melanoma/drug therapy; Skin Neoplasms/drug therapy; Antibodies, Monoclonal/adverse effects; Budesonide/administration & dosage; CTLA-4 Antigen/immunology; Diarrhea/etiology; Female; Follow-Up Studies; Humans; Ipilimumab; Male; Melanoma/mortality; Melanoma/pathology; Melanoma/physiopathology; Neoplasm Metastasis; Neoplasm Staging; Retrospective Studies; Skin Neoplasms/mortality; Skin Neoplasms/pathology; Skin Neoplasms/physiopathology; Survival Analysis

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Melanoma / Antibodies, Monoclonal Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Female / Humans / Male Language: En Journal: J Immunother Journal subject: ALERGIA E IMUNOLOGIA / NEOPLASIAS / TERAPEUTICA Year: 2012 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google